UBS has adjusted its price target for Vivendi after the company's recent split, reducing it from €10 to €3. However, the analyst still recommends buying the shares, as they believe the risk/reward ratio is attractive.

The revised target takes into account the changes within the company. Investors should consider this new valuation when making their decisions. It is important to consult with professional advisors before making any investment decisions, as this information is intended to assist in the decision-making process.